Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Fludarabine for Chronic Cold Agglutinin Disease
NCT00373594Phase 2Completed
- Sponsor
- University of Bergen
- Start
- Jun 2005
- Primary completion
- Apr 2010
- Modality
- Monoclonal Antibodies, Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
A Phase 2 trial of rituximab, fludarabine in cold agglutinin disease (CAD), sponsored by University of Bergen. Started Jun 2005; status: completed.
02
Drugs
rituximabfludarabine
03
Conditions
cold agglutinin disease (CAD)
Beyond the preview
Go deeper on NCT00373594.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00373594.